POLH Antibody

What is POLH antibody and what are its primary research applications?

POLH antibody is a reagent that specifically targets DNA polymerase eta (POLH), a specialized DNA polymerase involved in translesion synthesis during DNA replication. The primary research applications include:

• Western blotting (WB) at recommended dilutions of 1:500-1:1000

• ELISA-based detection methods

• Immunohistochemistry to visualize POLH localization

• Co-immunoprecipitation to study protein-protein interactions

When selecting a POLH antibody, researchers should consider the specific epitope targeted (e.g., POLH fusion protein Ag27973), host species (typically rabbit), and antibody class (polyclonal or monoclonal) . The POLH antibody is particularly useful in research involving DNA damage response, UV radiation exposure studies, and investigations of somatic hypermutation in immunoglobulin genes .

How should researchers validate POLH antibody specificity before experimental use?

Proper validation of POLH antibody specificity is crucial for reliable experimental results. A methodological approach includes:

• Western blot validation: Test the antibody against cell lines known to express POLH. The expected molecular weight for POLH is approximately 78-85 kDa, matching the calculated weight of 78 kDa . Validated cell lines include BxPC-3, HeLa, COLO 320, and HEK-293T cells .

• Positive and negative controls: Include lysates from POLH knockout cells or cells with POLH knockdown as negative controls. Compare band patterns with positive controls from cells overexpressing POLH.

• Cross-reactivity testing: Verify specificity by ensuring the antibody doesn't cross-react with other polymerase family members.

• Peptide competition assay: Pre-incubate the antibody with excess immunizing peptide to confirm specific binding is blocked.

• Reactivity verification: Confirm reactivity with human samples as indicated in product information .

Titration of the antibody is recommended for each testing system to obtain optimal results, as sensitivity can be sample-dependent .

What are the optimal storage conditions for maintaining POLH antibody activity?

To maintain optimal POLH antibody activity and prevent degradation, researchers should adhere to the following storage protocols:

Following these storage conditions will help ensure consistent antibody performance across experiments and maximize the usable lifetime of the reagent.

What controls should be included when using POLH antibody in Western blotting?

When performing Western blotting with POLH antibody, a comprehensive set of controls should be included to ensure valid and interpretable results:

• Positive control: Include lysates from cells known to express POLH, such as BxPC-3, HeLa, COLO 320, or HEK-293T cells . This control confirms that the antibody is working and identifies the correct band size (78-85 kDa) .

• Loading control: Include detection of a housekeeping protein (β-actin, GAPDH, or tubulin) to normalize for variations in loading amounts across lanes.

• Molecular weight marker: Use a precise molecular weight ladder to confirm the observed band corresponds to the expected size of POLH (calculated 78 kDa; observed 78-85 kDa) .

• Negative control: Include lysates from cells with POLH knocked down or knocked out, or use secondary antibody only to identify non-specific binding.

• Titration control: When first using the antibody, test multiple dilutions within the recommended range (1:500-1:1000) to determine optimal signal-to-noise ratio.

• Blocking peptide control: In cases where specificity is questioned, run a parallel blot with antibody pre-incubated with the immunizing peptide to confirm specific binding.

This systematic approach ensures that experimental observations attributable to POLH are valid and reproducible across different experimental conditions.

How can researchers troubleshoot weak or absent signal when using POLH antibody?

When encountering weak or absent signals with POLH antibody, researchers should implement the following troubleshooting strategies:

• Antibody dilution optimization:

  • Test multiple dilutions within and beyond the recommended range (1:500-1:1000)

  • Create a dilution series to identify the optimal concentration for your specific sample

• Sample preparation improvements:

  • Ensure complete cell lysis with appropriate detergents

  • Add protease inhibitors to prevent POLH degradation

  • Verify protein concentration using reliable quantification methods

  • Consider enriching for nuclear proteins, as POLH is primarily nuclear

• Protein transfer verification:

  • Use reversible staining of membranes to confirm efficient protein transfer

  • Optimize transfer conditions for high molecular weight proteins (78-85 kDa)

• Detection system enhancement:

  • Use more sensitive detection reagents (enhanced chemiluminescence)

  • Increase exposure time incrementally

  • Consider using HRP-conjugated secondary antibodies with higher sensitivity

• Reagent quality assessment:

  • Verify antibody integrity by testing against positive control cell lines (BxPC-3, HeLa, COLO 320, HEK-293T)

  • Check storage conditions and expiration dates

  • Prepare fresh buffers and blocking solutions

• Protocol modifications:

  • Increase incubation time with primary antibody (overnight at 4°C)

  • Adjust blocking conditions to reduce background while preserving specific signal

  • Follow manufacturer's specific protocol recommendations

If signal remains undetectable after these optimizations, consider whether POLH expression might be naturally low in your sample or induced only under specific conditions like DNA damage.

How can POLH antibody be used to investigate the role of polymerase eta in somatic hypermutation of immunoglobulin genes?

POLH antibody serves as a critical tool for investigating polymerase eta's role in somatic hypermutation (SHM) of immunoglobulin genes through several advanced methodological approaches:

• Chromatin immunoprecipitation (ChIP) analysis:

  • Use POLH antibody to immunoprecipitate chromatin from activated B cells

  • Perform qPCR or sequencing of precipitated DNA to identify POLH binding at immunoglobulin loci

  • Compare occupancy at actively mutating versus non-mutating regions

• Co-immunoprecipitation studies:

  • Use POLH antibody to pull down protein complexes

  • Identify SHM-related interaction partners (e.g., AID, UNG, MSH2/6)

  • Analyze how these interactions change under different conditions

• Mutation pattern analysis:

  • Compare A:T mutation frequencies in wild-type versus POLH-deficient cells

  • Use POLH antibody to validate POLH expression levels in experimental models

  • Correlate POLH protein levels with A:T mutation rates in immunoglobulin genes

• Subcellular localization studies:

  • Use immunofluorescence with POLH antibody to track recruitment to replication foci

  • Analyze colocalization with markers of DNA damage in germinal center B cells

  • Monitor temporal dynamics of POLH recruitment during antibody diversification

• Functional rescue experiments:

  • In POLH-deficient cells, reintroduce wild-type or mutant POLH

  • Use POLH antibody to confirm expression levels

  • Correlate mutational outcomes with POLH protein expression

Research has demonstrated that POLH is a limiting factor for A:T mutations in immunoglobulin genes , making POLH antibody an essential tool for investigating the mechanistic aspects of antibody diversification and affinity maturation.

What methodological considerations are important when using POLH antibody in multiplexed immunofluorescence experiments?

When conducting multiplexed immunofluorescence experiments with POLH antibody, researchers should address several critical methodological considerations:

• Antibody compatibility assessment:

  • Verify host species compatibility among all primary antibodies

  • Test for cross-reactivity between secondary antibodies

  • Consider using directly conjugated primary antibodies to reduce species constraints

• Spectral overlap management:

  • Select fluorophores with minimal spectral overlap

  • Include single-stained controls for spectral unmixing

  • Consider sequential staining approaches for closely overlapping fluorophores

• Staining protocol optimization:

  • Determine optimal fixation method (paraformaldehyde vs. methanol) that preserves POLH epitope

  • Test different antigen retrieval methods for each antibody in the panel

  • Optimize blocking conditions to minimize non-specific binding

• Signal amplification strategies:

  • For low-abundance POLH detection, consider tyramide signal amplification

  • Balance amplification needs with potential increased background

  • Validate that amplification doesn't introduce artifacts

• Colocalization analysis parameters:

  • Establish quantitative thresholds for colocalization with DNA damage markers

  • Use appropriate statistical methods for colocalization assessment

  • Account for random overlap in densely stained regions

• Validation experiments:

  • Include positive controls (UV-irradiated cells) to verify POLH detection

  • Use siRNA/shRNA knockdown controls to confirm antibody specificity

  • Perform parallel Western blot analysis to correlate with fluorescence intensity

• Image acquisition standardization:

  • Maintain consistent exposure settings across experimental conditions

  • Acquire z-stacks to capture the full nuclear volume

  • Use consistent thresholding in image analysis

These considerations help ensure reliable data interpretation when analyzing POLH localization in relation to other proteins involved in DNA damage response and repair pathways.

How can POLH antibody be used to study the relationship between polymerase eta dysfunction and cancer development?

POLH antibody serves as a valuable tool for investigating the complex relationship between polymerase eta dysfunction and carcinogenesis through several sophisticated research approaches:

• Clinical sample analysis:

  • Compare POLH expression levels across tumor and matched normal tissues

  • Correlate POLH expression with:

    • Mutational signatures (particularly UV-induced C→T transitions)

    • Clinical outcomes

    • Treatment response metrics

• Mutation burden assessment:

  • Use POLH antibody to stratify tumors by expression level

  • Perform whole-genome or exome sequencing

  • Analyze correlation between POLH protein expression and specific mutational signatures

• DNA damage response pathway investigation:

  • Examine colocalization of POLH with γH2AX foci in tumor cells

  • Quantify recruitment kinetics to sites of DNA damage

  • Compare response dynamics in cancer versus normal cells

• Functional assays in cancer models:

  • Establish POLH knockdown or overexpression in cancer cell lines

  • Validate expression changes using POLH antibody

  • Assess:

    Parameter	POLH Deficiency	POLH Overexpression
    UV sensitivity	Increased	Decreased
    Mutation rate	Altered pattern	Altered pattern
    Cisplatin response	Often increased	Often decreased
    Replication stress	Elevated	Variable

• Therapeutic response prediction:

  • Correlate POLH expression (by IHC with POLH antibody) with response to:

    • DNA damaging agents

    • PARP inhibitors

    • Immunotherapy

  • Develop predictive models incorporating POLH status

• Cancer stem cell characteristics:

  • Examine POLH expression in putative cancer stem cell populations

  • Correlate with stemness markers

  • Assess impact on therapeutic resistance

By applying POLH antibody in these research contexts, investigators can elucidate the mechanistic links between translesion synthesis defects and genomic instability that contributes to cancer development, progression, and treatment response.

What considerations are important when designing experiments to study POLH using quantitative PCR in conjunction with antibody validation?

When designing experiments that combine quantitative PCR (qPCR) for POLH gene expression analysis with POLH antibody validation, researchers should address several critical methodological considerations:

• Experimental design integration:

  • Plan coordinated sampling to enable direct comparison between mRNA and protein levels

  • Include appropriate time points that account for potential delays between transcription and translation

  • Design experiments that capture both baseline and induced POLH expression (e.g., post-UV exposure)

• qPCR-specific considerations for POLH:

  • Design primers that span exon-exon junctions to avoid genomic DNA amplification

  • Include reference genes with expression stability similar to POLH

  • Implement standard curves using known quantities of POLH template

  • Follow MIQE guidelines (Minimum Information for Publication of Quantitative Real-Time PCR Experiments)

• Quantitative correlation analysis:

  • Establish methodologies to correlate qPCR Cq values with Western blot band intensities

  • Apply appropriate normalization strategies for both techniques

  • Use standard statistical approaches for correlation analysis

• Technical validation parameters:

  • For qPCR:

    Parameter	Recommended Range	Importance
    PCR efficiency	90-110%	Critical for accurate quantification
    R² of standard curve	>0.98	Ensures linearity
    Cq variation in replicates	<0.5	Indicates precision
    NTC Cq	No amplification or Cq>38	Controls for contamination

  • For Western blot with POLH antibody:

    Parameter	Recommendation	Rationale
    Dilution range	1:500-1:1000	Optimizes signal-to-noise ratio
    Loading control	Housekeeping protein	Normalizes for loading variation
    Exposure time	Multiple exposures	Ensures linear dynamic range

• Functional validation approaches:

  • Knockdown validation: Confirm reduction at both mRNA (qPCR) and protein levels (antibody)

  • Induction validation: Quantify upregulation following UV exposure or replication stress

  • Specificity controls: Include POLH-null cells as negative controls for both methods

• Data integration strategies:

  • Apply appropriate statistical methods to integrate qPCR and antibody-based data

  • Consider time-course experiments to capture the relationship between transcription and translation

  • Develop mathematical models that account for mRNA stability and protein half-life

How can researcher's investigate the role of POLH in antibody polyreactivity using POLH antibodies?

Investigating POLH's role in antibody polyreactivity requires sophisticated experimental approaches combining POLH antibodies with advanced immunological techniques:

• POLH expression correlation with antibody polyreactivity:

  • Quantify POLH expression in B cell populations using POLH antibodies

  • Sort B cells based on the polyreactivity of their secreted antibodies

  • Analyze correlation between POLH expression levels and polyreactivity metrics

  • Compare POLH levels in naïve versus germinal center B cells

• Genetic manipulation studies:

  • Generate POLH knockdown/knockout in B cell lines

  • Confirm altered POLH expression using POLH antibodies via Western blot

  • Characterize changes in antibody sequence and polyreactivity profiles

  • Perform rescue experiments with wild-type or mutant POLH

• Mechanistic investigation of POLH's role in somatic hypermutation:

  • Use ChIP-seq with POLH antibodies to map genomic binding sites

  • Focus analysis on immunoglobulin loci and correlation with mutation patterns

  • Investigate relationship between A:T mutations and polyreactivity features

  • Quantify POLH recruitment to immunoglobulin loci during B cell activation

• Analysis of sequence features associated with polyreactivity:

  • Extract the following features from antibody sequences associated with polyreactivity:

    Feature	Correlation with Polyreactivity	POLH Relevance
    Heavy chain CDR hydrophobicity	Positive correlation	Potential POLH mutation preference
    Isoleucine/tryptophan/tyrosine content	Strong correlation (AUC 0.75-0.88)	Potential POLH target regions
    Paratope composition	Variable by region	Differential POLH activity

• Advanced sequencing approaches:

  • Perform paired heavy/light chain sequencing of antibodies with defined polyreactivity

  • Use machine learning to identify sequence features associated with polyreactivity

  • Correlate these features with known POLH mutation preferences

  • Analyze >300,000 paired antibody variable regions to achieve statistical power

• Polyreactivity assessment methodologies:

  • Test antibody binding to multiple polyreactivity reagents:

    • Ovalbumin

    • Soluble cytosolic proteins

    • Soluble membrane proteins

    • Insulin

  • Classify antibodies based on binding patterns

  • Correlate with POLH-dependent mutational signatures

This research approach would help elucidate whether POLH's role in somatic hypermutation directly influences antibody polyreactivity through specific sequence alterations, particularly in the heavy chain variable regions that have been shown to primarily mediate polyreactivity .